申请人:Chafeev Mikhail
公开号:US20090069408A1
公开(公告)日:2009-03-12
This invention is directed to, for example, compounds of formula (I):
wherein n, m, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
and R
8
are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, for the treatment of iron disorders. This invention is also directed to pharmaceutical compositions comprising the compounds and methods of using the compounds to treat iron disorders.
本发明涉及如下公式(I)的化合物,例如:其中n、m、R1、R2、R3、R4、R5、R6、R7和R8如本文所定义,作为立体异构体、对映异构体、互变异构体或其混合物;或其药学上可接受的盐、溶剂或前药,用于治疗铁代谢失调。本发明还涉及包含这些化合物的制药组合物以及使用这些化合物治疗铁代谢失调的方法。